S2N recently hosted an informal gathering of emerging med tech CEOs, a sort of group therapy session for people suffering from the form of temporary insanity that makes one want to be a healthcare entrepreneur.
Abbott
J&J’s $7B claim against Boston Scientific goes to the judge
Ishrak: ‘With COV We’ll do for ORs what we’ve done for cath labs’ | The week in medtech M&A
CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014
Abbott closes $250m Topera buyout
Guidant didn’t breach deal with J&J, says lawyer | Medtech legal news for the week of December 22, 2014
Ex-Abbott stent liaison alleges retaliation for compliance complaint
Merger & acquisition activity surges this year | The week in medtech M&A
Report: Lawyer says Guidant didn’t breach deal with J&J
Abbott Vascular lays off 100 in California
Abbott Vascular (NYSE:ABT) is laying off about 100 workers at a California plant it acquired when it bought a portion of Guidant Corp. in 2006.